These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 37228898)
21. Oral Administration of Human Polyvalent IgG by Mouthwash as an Adjunctive Treatment of Chronic Oral Candidiasis. Pedraza-Sánchez S; Méndez-León JI; Gonzalez Y; Ventura-Ayala ML; Herrera MT; Lezana-Fernández JL; Bellanti JA; Torres M Front Immunol; 2018; 9():2956. PubMed ID: 30627128 [No Abstract] [Full Text] [Related]
22. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295. Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593 [TBL] [Abstract][Full Text] [Related]
23. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Pienaar ED; Young T; Holmes H Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025 [TBL] [Abstract][Full Text] [Related]
24. [The incidence of oral candidiasis in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome from Yunnan, China]. Wen Y; Li C; Pei J; Bai J; Yang X; Duan K Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Aug; 49(8):454-8. PubMed ID: 25351215 [TBL] [Abstract][Full Text] [Related]
25. Candida infections in AIDS patients. Odds FC Int J STD AIDS; 1992; 3(3):157-60. PubMed ID: 1616960 [TBL] [Abstract][Full Text] [Related]
26. [Oral candidiasis: clinical features and control]. Yamamoto T Rinsho Byori; 2010 Oct; 58(10):1027-34. PubMed ID: 21077293 [TBL] [Abstract][Full Text] [Related]
28. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors. Paula SB; Morey AT; Santos JP; Santos PM; Gameiro DG; Kerbauy G; Sena EM; Ueda LT; Carneiro M; Pinge-Filho P; Yamauchi LM; Yamada-Ogatta SF J Infect Dev Ctries; 2015 Dec; 9(12):1350-9. PubMed ID: 26719941 [TBL] [Abstract][Full Text] [Related]
29. Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions. Lilly EA; Shetty KV; Leigh JE; Cheeks C; Fidel PL Med Mycol; 2005 Sep; 43(6):517-23. PubMed ID: 16323309 [TBL] [Abstract][Full Text] [Related]
30. Hierarchical pattern of mucosal candida infections in HIV-seropositive women. Imam N; Carpenter CC; Mayer KH; Fisher A; Stein M; Danforth SB Am J Med; 1990 Aug; 89(2):142-6. PubMed ID: 1974383 [TBL] [Abstract][Full Text] [Related]
31. The effects of HIV infection on oral mucosal immunity. Challacombe SJ; Naglik JR Adv Dent Res; 2006 Apr; 19(1):29-35. PubMed ID: 16672546 [TBL] [Abstract][Full Text] [Related]
32. Oral candidiasis and oral yeast carriage among institutionalised South African paediatric HIV/AIDS patients. Blignaut E Mycopathologia; 2007 Feb; 163(2):67-73. PubMed ID: 17295100 [TBL] [Abstract][Full Text] [Related]
33. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of dental caries, gingivitis, and oral hygiene in hospitalized AIDS cases in Kinshasa, Zaire. Tukutuku K; Muyembe-Tamfum L; Kayembe K; Mavuemba T; Sangua N; Sekele I J Oral Pathol Med; 1990 Jul; 19(6):271-2. PubMed ID: 2401961 [TBL] [Abstract][Full Text] [Related]
35. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Enwuru CA; Ogunledun A; Idika N; Enwuru NV; Ogbonna F; Aniedobe M; Adeiga A Afr Health Sci; 2008 Sep; 8(3):142-8. PubMed ID: 19357740 [TBL] [Abstract][Full Text] [Related]
36. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China. Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443 [TBL] [Abstract][Full Text] [Related]
37. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. Lortholary O; Petrikkos G; Akova M; Arendrup MC; Arikan-Akdagli S; Bassetti M; Bille J; Calandra T; Castagnola E; Cornely OA; Cuenca-Estrella M; Donnelly JP; Garbino J; Groll AH; Herbrecht R; Hope WW; Jensen HE; Kullberg BJ; Lass-Flörl C; Meersseman W; Richardson MD; Roilides E; Verweij PE; Viscoli C; Ullmann AJ; Clin Microbiol Infect; 2012 Dec; 18 Suppl 7():68-77. PubMed ID: 23137138 [TBL] [Abstract][Full Text] [Related]
38. Oral fungi in HIV: challenges in antifungal therapies. Nittayananta W Oral Dis; 2016 Apr; 22 Suppl 1():107-13. PubMed ID: 27109279 [TBL] [Abstract][Full Text] [Related]
39. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China. Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553 [TBL] [Abstract][Full Text] [Related]